> Back to EJC

Recent editions

  • July/August 2015
    Thomas Helleday on an exciting new class of drug, MTH1 inhibitors.
  • June 2015
    Lesley Seymour and Jan Bogaerts on the future of RECIST.
  • May 2015
    Paul Workman on strategies for overcoming resistance to new drugs.
  • April 2015
    Highlights from the TAT Congress in Paris.
  • March 2015
    Christopher Wild on the exposome, a measure of environmental exposure.
  • February 2015
    Mathematicians are developing a blood flow model for metastasis.
  • January 2015
    René Bernards on discovering effective drug combinations.
  • December 2014
    Research on the high rate of burnout among young oncologists.
  • November 2014
    Carl June on the efficacy of CAR-T cells in treating leukaemia.
  • October 2014
    News from ESMO 2014 with Solange Peters and Alexander Eggermont.
  • September 2014
    Discussing how healthcare systems can meet the needs of cancer survivors.

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – June 2013

Loading EJC News Focus video

European Cancer Congress, Amsterdam (27 Sept – 1 Oct)

This autumn, Amsterdam will host the biennial European Cancer Congress with a wide-ranging programme encompassing everything from basic, applied and translational research to practice, treatment, care, prevention and advocacy for cancer patients. This is European oncology's premier multidisciplinary meeting and it will provide a forum for discussion of the latest developments in research and in the clinic.

Key to the congress is dynamic collaboration between specialties: its strapline is 'Reinforcing Multidisiplinarity'. It's a theme close to the heart of co-scientific chair, John Yarnold and here he tells Helen Saul why something we've been talking about for so many years, still needs to be emphasised.